No association of NAFLD-related polymorphisms in PNPLA3 and TM6SF2 with all-cause and cardiovascular mortality in an Austrian population study

Jonas W, Schürmann A. Genetic and epigenetic factors determining NAFLD risk. Mol Metab. 2021;50:101111.

Article  CAS  PubMed  Google Scholar 

Speliotes EK, et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 2011;7(3):e1001324.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Balcar L, et al. PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary center. Dig Liver Dis. 2022;54(1):84–90.

Article  PubMed  Google Scholar 

Unalp-Arida A, Ruhl CE. Patatin-like phospholipase domain-containing protein 3 I148M and liver fat and fibrosis scores predict liver disease mortality in the U.S. population. Hepatology. 2020;71(3):820–34.

Article  CAS  PubMed  Google Scholar 

Abul-Husn NS, et al. A protein-truncating HSD17B13 variant and protection from chronic liver disease. N Engl J Med. 2018;378(12):1096–106.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu YL, et al. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. Nat Commun. 2014;5:4309.

Article  CAS  PubMed  Google Scholar 

Mancina RM, et al. The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent. Gastroenterology. 2016;150(5):1219–1230e6.

Article  CAS  PubMed  Google Scholar 

Strnad P, et al. Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis. Gut. 2019;68(6):1099–107.

Article  CAS  PubMed  Google Scholar 

Holmen OL, et al. Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk. Nat Genet. 2014;46(4):345–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kahali B, et al. TM6SF2: catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease? Gastroenterology. 2015;148(4):679–84.

Article  PubMed  Google Scholar 

Dongiovanni P, et al. Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease. Hepatology. 2015;61(2):506–14.

Article  CAS  PubMed  Google Scholar 

Liu DJ, et al. Exome-wide association study of plasma lipids in 〉300,000 individuals. Nat Genet. 2017;49(12):1758–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Simons N, et al. PNPLA3, TM6SF2, and MBOAT7 genotypes and coronary artery disease. Gastroenterology. 2017;152(4):912–3.

Article  CAS  PubMed  Google Scholar 

Wernly S, et al. A sex-specific propensity-adjusted analysis of colonic adenoma detection rates in a screening cohort. Sci Rep. 2021;11(1):17785.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Semmler G, et al. Nut consumption and the prevalence and severity of non-alcoholic fatty liver disease. PLoS ONE. 2020;15(12):e244514.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eslam M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020; https://doi.org/10.1016/j.jhep.2020.03.039.

Article  PubMed  Google Scholar 

Wilson PW, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–47.

Article  CAS  PubMed  Google Scholar 

group, S.w., E.C.r. collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42(25):2439–54.

Article  Google Scholar 

Kedenko L, et al. Genetic polymorphisms at SIRT1 and FOXO1 are associated with carotid atherosclerosis in the SAPHIR cohort. BMC Med Genet. 2014;15:112.

Article  PubMed  PubMed Central  Google Scholar 

Rodriguez S, Gaunt TR, Day IN. Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol. 2009;169(4):505–14.

Article  PubMed  PubMed Central  Google Scholar 

Krawczyk M, Liebe R, Lammert F. Toward genetic prediction of nonalcoholic fatty liver disease trajectories: PNPLA3 and beyond. Gastroenterology. 2020;158(7):1865–1880.e1.

Article  CAS  PubMed  Google Scholar 

Rüschenbaum S, et al. Patatin-like phospholipase domain containing 3 variants differentially impact metabolic traits in individuals at high risk for cardiovascular events. Hepatol Commun. 2018;2(7):798–806.

Article  PubMed  PubMed Central  Google Scholar 

Wijarnpreecha K, et al. PNPLA3 gene polymorphism and overall and cardiovascular mortality in the United States. J Gastroenterol Hepatol. 2020;35(10):1789–94.

Article  CAS  PubMed  Google Scholar 

BasuRay S, et al. Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis. Proc Natl Acad Sci USA. 2019;116(19):9521–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scorletti E, Carr RM. A new perspective on NAFLD: focusing on lipid droplets. J Hepatol. 2022;76(4):934–45.

Article  CAS  PubMed  Google Scholar 

Luo F, Oldoni F, Das A. TM6SF2: a novel genetic player in nonalcoholic fatty liver and cardiovascular disease. Hepatol Commun. 2022;6(3):448–60.

Article  CAS  PubMed  Google Scholar 

Pirola CJ, Sookoian S. The dual and opposite role of the TM6SF2-rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: A meta-analysis. Hepatology. 2015;62(6):1742–56.

Article  CAS  PubMed  Google Scholar 

Stojkovic IA, et al. The PNPLA3 Ile148Met interacts with overweight and dietary intakes on fasting triglyceride levels. Genes Nutr. 2014;9(2):388–388.

Article  PubMed  PubMed Central  Google Scholar 

Krarup NT, et al. The PNPLA3 rs738409 G‑allele associates with reduced fasting serum triglyceride and serum cholesterol in danes with impaired glucose regulation. PLoS ONE. 2012;7(7):e40376.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krawczyk M, et al. The common adiponutrin variant p.I148M does not confer gallstone risk but affects fasting glucose and triglyceride levels. J Physiol Pharmacol. 2011;62(3):369–75.

CAS  PubMed  Google Scholar 

Kantartzis K, et al. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes. 2009;58(11):2616–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Valenti L, et al. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology. 2010;51(4):1209–17.

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif